TY - CONF T1 - 171 Prevalence of a nice-defined indication for inclisiran in a real-world trans-pandemic acute coronary syndrome cohort JO - Stable IHD/Prevention/Hypertension/Lipids UR - http://dx.doi.org/10.1136/heartjnl-2022-bcs.171 PY - 2022/06/06 AU - Shaji N AU - Elamin N AU - Nelson T AU - Varian F AU - Storey R AU - Parker W ED - DO - DOI: 10.1136/heartjnl-2022-bcs.171 PB - BMJ Publishing Group Ltd and British Cardiovascular Society Y2 - 2024/12/22 ER -